Delivery Order SPE2DB22D1017-SPE2DB24FF4HT
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award, valued at $11,143.75, is a firm fixed price delivery order for the pharmaceutical product Eliquis 5 mg tablet 60s. The contract has a performance period through March 15, 2024 and does not include a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a separate indefinite delivery...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide Eliquis 5 mg tablets to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The award is a firm fixed price delivery order under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to supply pharmaceuticals and medical supplies to DLA...
- This federal contract award, valued at $11,362.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is a firm fixed price delivery order for 4,563,970,681 units of the pharmaceutical product Eliquis 5 mg tablets. The contract has a performance period through March 15, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Eliquis 5 mg tablets. The contract, valued at $17,951.80, is a firm fixed price delivery order with an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $33,114.55, is a firm fixed price delivery order for the supply of Eliquis 5 mg tablets. The award does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $13,804.24 firm fixed price delivery order is for the supply of Eliquis 5mg tablets. The award is part of a larger indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $10,417.54 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $26,407.59 firm fixed price delivery order is for the supply of Eliquis 5 mg tablet 60s, a pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,642.00 firm fixed price contract is for the delivery of Eliquis 5 mg tablet 60s, a brand name anticoagulant medication. The award has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp serves as a prime contractor to DLA, providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,865.14 firm fixed price delivery order is for the supply of Eliquis 5 mg tablets. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF4HTDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $13,653.65, is for the delivery of Eliquis 5 mg tablets, a pharmaceutical product. The contract is a firm fixed price delivery order with a performance period through March 18, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also been awarded an indefinite delivery contract (IDC) by DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 3/15/24 |